Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 10:4:2.
doi: 10.1186/s41927-019-0102-7. eCollection 2020.

Patient perspectives on the pathway to psoriatic arthritis diagnosis: results from a web-based survey of patients in the United States

Affiliations

Patient perspectives on the pathway to psoriatic arthritis diagnosis: results from a web-based survey of patients in the United States

Alexis Ogdie et al. BMC Rheumatol. .

Abstract

Background: There are limited real-world data on the diagnostic experiences of patients with psoriatic arthritis (PsA), including medical care sought and potential barriers to diagnosis. We aim to describe patient experiences related to receiving a PsA diagnosis.

Methods: Ours was a mixed-method, 2-phase study. Phase 1 comprised concept elicitation and cognitive interviews with clinical experts and adults diagnosed with PsA to develop a cross sectional, web-based survey. US adults with a self-reported PsA diagnosis were recruited through a patient support community (CreakyJoints), an online patient research registry (ArthritisPower), and social media outreach. In Phase 2, the online survey collected data on sociodemographics, clinical symptoms, disease burden, and diagnosis history of survey respondents with PsA.

Results: Of the 203 respondents included, 172 (84.7%) were female, and the mean (SD) age was 51.6 (10.8) years. The time between seeking medical attention and receiving a diagnosis was < 6 months for 69 respondents, 6 months to 4 years for 68 respondents, and ≥ 5 years for 66 respondents. Most respondents sought care from general practitioners (79.8%) and rheumatologists (66.5%). Common initial symptoms that led respondents to seek medical attention were joint pain (70.0%) and stiffness (53.7%). Among the initial symptoms that led respondents to seek care, joint pain, swollen joints, and sausage-like fingers or toes (indicating dactylitis) were more common among respondents with shorter time to diagnosis, whereas stiffness, fatigue, enthesitis (indicated by foot problems, tendon and ligament pain), and back pain were more common among respondents with longer time to diagnosis. Common misdiagnoses were psychosomatic issues (26.6%) and osteoarthritis (21.7%). Respondents with shorter times to diagnosis had lower frequencies of misdiagnosis.

Conclusions: Respondents with PsA reported delays in diagnosis and misdiagnoses on their journey to a PsA diagnosis. Symptom differences, such as enthesitis and stiffness, were noted among respondents with shorter vs longer time to diagnosis. Increased understanding of diagnostic barriers may lead to earlier diagnosis and appropriate management to improve outcomes.

Keywords: Diagnosis; Psoriatic arthritis; Spondyloarthropathy; Surveys and questionnaires.

PubMed Disclaimer

Conflict of interest statement

Competing interestsA. Ogdie has received consulting fees from AbbVie, Amgen, BMS, Celgene, Lilly, Novartis, Pfizer, and Takeda, and has received grant support from the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases, Rheumatology Research Foundation, Pfizer, and Novartis. W. B. Nowell, K. Gavigan, and S. Venkatachalam are employees of Global Healthy Living Foundation. E. Applegate is a patient advocate affiliated with Global Healthy Living Foundation. M. de la Cruz, B. Romero, and E. Schwartz are employees of ICON, which was contracted by Novartis to conduct the study; E. Flood was an employee of ICON at the time of the analysis. P. Hur is an employee of Novartis Pharmaceuticals Corporation.

Figures

Fig. 1
Fig. 1
Common first symptoms to prompt seeking health care among respondents with PsA, stratified by time between seeking medical attention and receiving formal diagnosis.* PsA: psoriatic arthritis. * Respondents could have selected > 1 option
Fig. 2
Fig. 2
Type(s) of healthcare providers seen during the PsA diagnosis process, stratified by time between seeking medical attention and receiving formal diagnosis.* ED: emergency department; PsA: psoriatic arthritis. * Respondents could have selected > 1 option. P < 0.05 comparing respondents with time to PsA diagnosis of < 6 months, 6 months to 4 years, and ≥ 5 years
Fig. 3
Fig. 3
Misdiagnoses received prior to official PsA diagnosis among respondents with PsA, stratified by time between seeking medical attention and receiving formal diagnosis.* PsA: psoriatic arthritis. * Respondents could have selected > 1 option. P < 0.05 comparing respondents with time to PsA diagnosis of < 6 months, 6 months to 4 years, and ≥ 5 years

References

    1. Madland TM, Apalset EM, Johannessen AE, Rossebö B, Brun JG. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol. 2005;32(10):1918–1922. - PubMed
    1. Brockbank J, Gladman D. Diagnosis and management of psoriatic arthritis. Drugs. 2002;62(17):2447–2457. doi: 10.2165/00003495-200262170-00004. - DOI - PubMed
    1. Gladman DD. Current concepts in psoriatic arthritis. Curr Opin Rheumatol. 2002;14(4):361–366. doi: 10.1097/00002281-200207000-00005. - DOI - PubMed
    1. Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376(10):957–970. doi: 10.1056/NEJMra1505557. - DOI - PubMed
    1. Ogdie A, Schwartzman S, Husni ME. Recognizing and managing comorbidities in psoriatic arthritis. Curr Opin Rheumatol. 2015;27(2):118–126. doi: 10.1097/BOR.0000000000000152. - DOI - PubMed